Back
RedHill Biopharma Ltd. 10K Form
Sell
30
RDHL
RedHill Biopharma Ltd.
Last Price:
$1.20
Seasonality Move:
-10.63%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive RDHL News And Ratings
See the #1 stock for the next 7 days that we like better than RDHL
RDHL Financial Statistics
Sales & Book Value
| Annual Sales: | $8.1M |
|---|---|
| Cash Flow: | $0 |
| Price / Cash Flow: | 0 |
| Annual Sales: | $0.05 |
| Price / Book: | 1.13 |
Profitability
| Net Income (TTM): | $0 |
|---|---|
| Gross Margin: | $4.9M |
| Return on Equity: | 0% |
| Return on Assets: | 0% |
RedHill Biopharma Ltd. Earnings Forecast
Key RedHill Biopharma Ltd. Financial Ratios
-
The Gross Profit Margin over the past 16 years for RDHL is 60.31%.
-
The Selling, General & Administrative Expenses for RDHL have been equal to 192.92% of Gross Profit Margin.
-
The Research & Development expenses have been 19.74% of Revenue.
-
The Net Earning history of RDHL is -102.80% of Total Revenues.
-
Per Share Earnings over the last 16 years have been positive in 8 years.
RedHill Biopharma Ltd. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Pharmaceuticals |
| Sector: | Health Care |
| Current Symbol: | RDHL |
| CUSIP: | 757468 |
| Website: | redhillbio.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 0.74 |
| Quick Ratio: | 0.53 |
Price-to-Earnings
| Trailing P/E Ratio: | 0.02 |
|---|---|
| Forward P/E Ratio: | 0 |
RDHL Technical Analysis vs Fundamental Analysis
Sell
30
RedHill Biopharma Ltd. (RDHL)
is a Sell
Is RedHill Biopharma Ltd. a Buy or a Sell?
-
RedHill Biopharma Ltd. stock is rated a SellThe current RedHill Biopharma Ltd. [RDHL] share price is $1.18. The Score for RDHL is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.